How have BEAM and PDSB total returns compared?

Over the past 5 years, BEAM delivered -22.35% and PDSB delivered -45.19% annualized total return. Past performance doesn't predict future results.

Beam Therapeutics Inc. (BEAM) vs PDS Biotechnology Corporation (PDSB)

A side-by-side comparison of Beam Therapeutics Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

BEAM

Beam Therapeutics Inc.

$2.52B

$24.50HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

PDSB

PDS Biotechnology Corporation

$42M

$0.75HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — BEAM vs PDSB

growth of $100 · dividends reinvested · last 7y

BEAM +30.1% (+3.8%/yr)PDSB -73.3% (-17.2%/yr)BEAM compounded faster over this window

BEAM PDSB

BEAM vs PDSB: by the numbers

•BEAM is the larger company ($2.52B vs $42M market cap).
•Both run net losses; PDSB's is the smaller (0.00% vs -54.75% net margin).

Metrics side by side

Valuation

Metric	BEAM	PDSB
P/S ratio	16.15	N/A
P/B ratio	2.36	N/A

Profitability

Metric	BEAM	PDSB
Gross margin	84.05%	0.00%
Operating margin	-274.57%	0.00%
Net margin	-54.75%	0.00%
ROE	-8.00%	N/A
ROIC	-28.96%	-3699.99%

Growth (annualized)

Metric	BEAM	PDSB
Revenue CAGR (5Y)	479.04%	N/A
Total return CAGR (5Y)	-22.35%	-45.19%

Frequently asked

How have BEAM and PDSB total returns compared?: Over the past 5 years, BEAM delivered -22.35% and PDSB delivered -45.19% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BEAM analysis Full PDSB analysis Interactive comparison tool

Dig into the metrics

Beam Therapeutics ROE PDS Biotechnology ROE Beam Therapeutics operating margin PDS Biotechnology operating margin Beam Therapeutics revenue growth PDS Biotechnology revenue growth Beam Therapeutics free cash flow PDS Biotechnology free cash flow

Beam Therapeutics & PDS Biotechnology appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.